- Home
- POLA vs ABVC Comparison
POLA vs ABVC Comparison
Compare POLA & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- ABVC
- Stock Information
- Founded
- POLA 1979
- ABVC 2015
- Country
- POLA United States
- ABVC United States
- Employees
- POLA N/A
- ABVC N/A
- Industry
- POLA Industrial Machinery/Components
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- POLA Miscellaneous
- ABVC Health Care
- Exchange
- POLA Nasdaq
- ABVC Nasdaq
- Market Cap
- POLA 7.7M
- ABVC 6.5M
- IPO Year
- POLA 2016
- ABVC N/A
- Fundamental
- Price
- POLA $0.46
- ABVC $0.50
- Analyst Decision
- POLA
- ABVC
- Analyst Count
- POLA 0
- ABVC 0
- Target Price
- POLA N/A
- ABVC N/A
- AVG Volume (30 Days)
- POLA 161.1K
- ABVC 232.1K
- Earning Date
- POLA 11-14-2024
- ABVC 11-14-2024
- Dividend Yield
- POLA N/A
- ABVC N/A
- EPS Growth
- POLA N/A
- ABVC N/A
- EPS
- POLA N/A
- ABVC N/A
- Revenue
- POLA $14,953,000.00
- ABVC $509,788.00
- Revenue This Year
- POLA $6.72
- ABVC N/A
- Revenue Next Year
- POLA N/A
- ABVC N/A
- P/E Ratio
- POLA N/A
- ABVC N/A
- Revenue Growth
- POLA N/A
- ABVC N/A
- 52 Week Low
- POLA $0.32
- ABVC $0.41
- 52 Week High
- POLA $0.90
- ABVC $2.45
- Technical
- Relative Strength Index (RSI)
- POLA 49.27
- ABVC 37.57
- Support Level
- POLA $0.43
- ABVC $0.50
- Resistance Level
- POLA $0.53
- ABVC $0.58
- Average True Range (ATR)
- POLA 0.05
- ABVC 0.06
- MACD
- POLA 0.00
- ABVC -0.01
- Stochastic Oscillator
- POLA 45.07
- ABVC 1.82
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications primarily in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, Back-up DC generators, hybrid power systems, Li-Ion battery systems, and Marine DC generators. The Companie's geographical presence is in the United States, Canada, Mexico, South Pacific Islands, Japan, Europe and Middle East and Other Asia Pacific countries.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.